The Zyprexa story

Pharmaceutical company Eli Lilly (makers of Prozac) have agreed to pay upwards of 1.2 billion US dollars to nearly 30,000 patients who claim their bestseller antipsychotic medication, Zyprexa (Olanzapine) has resulted in diabetes, weight gain and other complications and that these risks were downplayed. Secret documents are leaked, the newspaper headlines start screaming, and citizen journalists spread the word - but where is the real advocacy for better drugs with fewer side effects?